HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

ACTILYSE overview
Acute myocardial infarction; acute pulmonary embolism.

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
ACTILYSE
Drug Class Description :

Fibrinolytics.

Generic Name :

Alteplase

Drug description :

Powder in vial plus diluent.

Presentation :

Powder for injection, alteplase 10 mg , 20 mg , 50 mg .

Indications :

Acute myocardial infarction; acute pulmonary embolism.

Adult Dosage :

Total dose of 100 mg intravenously over three hours. MI: administer over 90 minutes if within 6 hours of symptom onset, over 3 hours if 6 - 12 hours. PE: administer over 2 hours. See Summary of Product Characteristics.

Child Dosage :

Not recommended.

Contra Indications :

Situations where there is a high risk of haemorrhage such as: bleeding diathesis, within 10 bleeding diathesis, within 10 days of haemorrhage or surgery, active peptic ulceration, acute pancreatitis, bacterial endocarditis, severe liver disease; history of stroke or CNS damage; severe controlled hypertension.

Special Precautions :

Situations where risk of bleeding is increased. Pregnancy. Elderly. Actilyse should be given only by physicians experienced in the use of thrombolytics and with the facilities to monitor it.

Interactions :

Anticoagulants.

Adverse Reactions :

Bleeding is the most frequent adverse reaction. This may be superficial bleeding from punctures or damaged blood vessels, or internal bleeding into the urogenital tract, retroperitoneum or CNS or bleeding of parenchymatous organs. Intracranial haemorrhage. Cholesterol crystal embolisation or thrombotic embolisation rarely. Arrhythmias associated with reperfusion may occur. Nausea, vomiting, hypotension and fever may occur rarely.

Manufacturer :

Boehringer Ingelheim

Drug Availability :

(POM)

Drug Updated :

01 May 2001

Related Drugs - Anticoagulants, antithrombotics & fibrinolytics
Niemann-Pick Type C Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. Opioid and Pain Management - understanding, management, diagnosis and treatment information Ophthalmics - understanding, management, diagnosis and treatment information
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES